In addition, Bcl-2 and cellular inhibitor of apoptosis protein 1 (c-IAP1) were downregulated upon hyperglycemia treatment, whereas Mfn2 silencing restored the expressions of these proteins in cardiomyocytes (Figures 2D–I). The gene discussed is BCL2; the disease is Hyperglycemia.